Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
DCF Valuation
Base-case fair value
€13.11
Intrinsic €17.48 · 25% MOS
Base-case summary
Our base-case DCF for Bayer AG (BAYN.XETR) projects 10 years of free cash flow growth at 2.0% for years 1–5 and 1.0% for years 6–10, anchored to 1.3% historical FCF growth, then applies a 2.5% perpetual growth rate and a 8.0% discount rate. Starting from €2.6B in trailing free cash flow, this produces an intrinsic value of €17.48 per share. A 25% safety margin gives a fair value of €13.11.
See 3 scenarios side by side
Conservative, Base, and Optimistic fair values, plus the sensitivity matrix and FCF history. Free account.
Model inputs
TTM Free Cash Flow
€2.6B
Cash & equivalents
€7.9B
Total debt
€36.5B
Shares outstanding
982M